The Food and Drugs Authority (FDA) has revoked
marketing authorisation permits for the sale and distribution of six vitality
herbal medicines for men.
The products are Rockman Capsules,
manufactured by RockCare Clinic; Angel Natural Capsules by Angel Herbal Products
Industry and
Tinattet Be4 Be4 Capsules by Tinattet Marketing Co. Ltd.
The
others are Adom Gentleman Power Capsules, manufactured by Dependable Pharmacy;
Laud P Capsules by the Stephen Gyan Herbal Centre and Mars for Men, imported by
Joe D.D. Ventures.
All the products were found to have been adulterated
with Vardenafil, a synthetic pharmaceutical ingredient used in the formulation
of prescription-only medicine for the treatment of erectile
dysfunction.
Vardenafil is closely related in function to
Viagra.
Ironically, checks by the Daily Graphic indicates that some of
the banned sex ‘drugs’ have FDA certification.
But some players in the
herbal preparation industry question the move by the FDA saying that unless the
certification was fake the FDA had to answer some
questions.
Notice
The FDA has subsequently served notice to the
above-mentioned companies to immediately halt all advertisement of the products
and cooperate with the authority to recall those already on the market.
A
statement signed by the Chief Executive Officer (CEO) of the FDA, Mr Hudu
Mogtari, and issued by the authority in Accra yesterday said the use of
Vardenafil might have serious health implications such as cerebro-vascular
hemorrhage (bleeding in the brain) which could lead to stroke.
“It could
even cause heart attack, palpitation and serious cardiovascular events,
including sudden cardiac death,” it said.
Explaining further, Mr Mogtari
said the adulteration of the products could also lead to sustained erection and
the resultant factor could be impotence.
“Kidney failure, problems with
sight and hearing can also not be ruled out,” he said.
He cautioned the
public against the continued patronage of the herbal medicines.
Market
recall
Mr Mogtari said the authority had put in place a monitoring mechanism
to ensure that the producers, distributors and marketers did not sell the
products on the blind side of the FDA.
He also hinted of possible
sanctions against the manufacturers and distributors of the six
products.
The FDA was also appealing to the public to provide information
on persons dealing in the products, as well as others which could endanger
public health and safety, he added. |
|
|
|
|
No comments:
Post a Comment